A Multicenter Phase 2 Study of Oral N-Acetyl Dinaline (CI-994) in the Treatment of Patients With Advanced Myeloma
Latest Information Update: 17 Jul 2015
At a glance
- Drugs Tacedinaline (Primary)
- Indications Myeloma
- Focus Therapeutic Use
- 18 Sep 2005 New trial record.